Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study.

Hill DA, Prossnitz ER, Royce M, Nibbe A.

PLoS One. 2019 Oct 24;14(10):e0224064. doi: 10.1371/journal.pone.0224064. eCollection 2019.

2.

Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics.

Blair CK, Wiggins CL, Nibbe AM, Storlie CB, Prossnitz ER, Royce M, Lomo LC, Hill DA.

NPJ Breast Cancer. 2019 Oct 2;5:33. doi: 10.1038/s41523-019-0128-4. eCollection 2019.

3.

Estrogen receptor quantitative measures and breast cancer survival.

Hill DA, Barry M, Wiggins C, Nibbe A, Royce M, Prossnitz E, Lomo L.

Breast Cancer Res Treat. 2017 Dec;166(3):855-864. doi: 10.1007/s10549-017-4439-6. Epub 2017 Aug 19.

4.

Method of detection and breast cancer survival disparities in Hispanic women.

Hill DA, Nibbe A, Royce ME, Wallace AM, Kang H, Wiggins CL, Rosenberg RD.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2453-60. doi: 10.1158/1055-9965.EPI-10-0164. Epub 2010 Sep 14.

5.

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.

Goetz MP, Knox SK, Suman VJ, Rae JM, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Weinshilboum RM, Fritcher EG, Nibbe AM, Desta Z, Nguyen A, Flockhart DA, Perez EA, Ingle JN.

Breast Cancer Res Treat. 2007 Jan;101(1):113-21. Epub 2006 Nov 18.

PMID:
17115111
6.

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7.

7.

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL.

Clin Cancer Res. 2005 May 15;11(10):3722-32.

8.

Lung abscess secondary to vibrio fetus, malabsorption syndrome and acquired agammaglobulinemia.

Lawrence R, Nibbe AF, Levin S.

Chest. 1971 Aug;60(2):191-4. No abstract available.

PMID:
5571479
9.

Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation. Effect of prednisone.

Ryan WG, Schwartz TB, Nibbe AF.

Diabetes. 1971 Jun;20(6):410-5. No abstract available.

PMID:
4933891
10.

Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation.

Ryan WG, Schwartz TB, Nibbe AF.

Diabetes. 1971 Jun;20(6):404-9. No abstract available.

PMID:
4933890
11.

Fibrous dysplasia of bone with vitamin D resistant rickets: a case study.

Ryan WG, Nibbe AF, Schwartz TB, Ray RD.

Metabolism. 1968 Nov;17(11):988-98. No abstract available.

PMID:
5724172
12.

Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.

Ryan WG, Nibbe AF, Schwartz TB.

Lancet. 1967 Jun 10;1(7502):1255-6. No abstract available.

PMID:
4165041
13.

Intrinsic renal mechanisms for the regulation of body electrolytes in man.

Baldwin D, Nibbe AF, Schwartz TB.

Metabolism. 1966 Apr;15(4):338-58. No abstract available.

PMID:
5905291

Supplemental Content

Support Center